Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2008
02/27/2008CN101129361A Sirolimus lipidosome freeze-dried acanthopanax powder and technique of preparing the same
02/27/2008CN101129360A Diffluent antibacterial drugs composition pharmaceutical formulation, method of preparing the same and use thereof
02/27/2008CN101129359A Pharmaceutical composition containing amoxicillin, ambroxol and beta lactamase restrainer and uses thereof
02/27/2008CN101129358A Moguisteine sustained-release tablet and method of preparing the same
02/27/2008CN101129357A Pharmaceutical composition containing fipronil and application of the same in preparing medicament for killing auricular mite for animals
02/27/2008CN101129356A Application of lovastatin in preparing medicament for restraining apoptosis of mesenchymal stem cell between medullas
02/27/2008CN101129355A Lovastatin sustained-release tablets and method of producing the same
02/27/2008CN101129354A Pharmaceutical composition containing triacetyl andrographolidume and medical use of the same
02/27/2008CN101129353A Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket
02/27/2008CN101129352A Use of oral conjugation linolic acid calcium for skin beauty treatment
02/27/2008CN101129351A Iron supplement composition, its preparing method and application of the same
02/27/2008CN101129350A Eye drops used for treating cataract and cloudy vitreous turbidity of persons in middle and old age, and method for preparing the same
02/27/2008CN101129349A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
02/27/2008CN101129348A Use of dipropylacetic acid or its salt in treating tumour
02/27/2008CN101129347A Florfenicol oil emulsion injection and method for formulating the same
02/27/2008CN101129346A Ambroxol hydrochloride oral cavity disintegrating tablet and method of producing the same
02/27/2008CN101129345A Vitamin K1 injection and method of producing the same
02/27/2008CN101129344A Methods, assays and compositions for treating retinol-related diseases
02/27/2008CN101129343A Application of beta-caryophyllene alcohol in preparing medicament for codein and/or eliminating phlegm
02/27/2008CN101129342A Method of producing hepatic targeting drug microcapsule
02/27/2008CN101129341A Intra-oral disintegration compositions and process for producing same
02/27/2008CN101129338A Minuteness anti-cancer medicine paclitaxel of novel technique supercritical fluid
02/27/2008CN101129337A Method of producing water-solubility hypocrellin titanium dioxide nano granule
02/27/2008CN101129335A Use of nano structured lipid carrier drug feeding system
02/27/2008CN101129332A Malotilate dry emulsion and method of preparing the same
02/27/2008CN101129331A Method of preparing transparent water dispersion type lycopene concentrated liquor
02/27/2008CN101129330A Method of preparing maduramicin ammonium microemulsion
02/27/2008CN101129329A Injection containing huperzine for sulci venosi and method of preparing the same
02/27/2008CN101129328A Compound aminophenazone barbital Injection and method of producing the same
02/27/2008CN101129327A Micro-projection array having a beneficial agent containing coating
02/27/2008CN101129188A Legalon mastication patch and method of preparing the same
02/27/2008CN100371714C Methods and compositions for treatment of central nervous system disorders
02/27/2008CN100371707C Method for measuring tepene lactone content in compositions extracted from Ginkgo biloba leaves
02/27/2008CN100371450C Fatty acid extract of Antrodiacamphorata mycelium and its uses
02/27/2008CN100371350C Microbe composite polysaccharide for suppressing cancer cell and its preparation method
02/27/2008CN100371344C Cerbera manghas heteroside derivative, its preparing method and use
02/27/2008CN100371340C Production of Rhizoma Picrorhizae glucoside II monomer and its drug form for treating hepatitis B
02/27/2008CN100371336C Pyrrole derivatives for treating diseases of cytokine mediated
02/27/2008CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
02/27/2008CN100371328C Substituted benzoyl carbamidine derivative, its preparation method and medical uses
02/27/2008CN100371326C New substituted pyridine or pyridine compound, their producing process and pharmaceutical composition containing them
02/27/2008CN100371325C Indenoindole ketone kind compound, its preparation method and use
02/27/2008CN100371324C Dialkyl and diaryl tetrasubstituted heterocyclic compounds, preparing process and use thereof
02/27/2008CN100371323C Cyanopyrrolidine derivatives
02/27/2008CN100371322C 2-pyrrolidone derivatives as prostanoid agonists
02/27/2008CN100371319C Preparation and application of N-[2-(aryloxy)ethyl]-2-(arylthio) benzyl amine derivative
02/27/2008CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
02/27/2008CN100370998C Chinese medicinal preparation for treating sore, and wound and turn and scald
02/27/2008CN100370996C Soft capsule of forest frogoil, royal jelly and seed kernel oil of pinus pumila reg, and its preparing process
02/27/2008CN100370995C Sodium triphosphate transfusion and its preparation technique
02/27/2008CN100370994C Ointment with clindamycin and metronidazole and method for preparing the same
02/27/2008CN100370993C Medicinal composition with heat-clearing, fire-draining and detoxification function
02/27/2008CN100370992C Doxycycline hydrochloride freeze-dried power preparation for injection, and process for preparing same
02/27/2008CN100370991C Pharmaceutical composition with anti-inflammation action
02/27/2008CN100370990C Controlled release galantamine composition
02/27/2008CN100370989C Use of 5-HT5-ligands in treatment of neurodegenerative and neuropsychiatric disturbances
02/27/2008CN100370988C Method of using (2-imidazolin-2-ylamino) qinoxalines in the treatment of dementia and Parkinsons
02/27/2008CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene
02/27/2008CN100370986C Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients
02/27/2008CN100370985C Externally applied sprayer formulation for sweat control and deodorization
02/27/2008CN100370984C Telmisartan dispersible tablet and its preparation method
02/27/2008CN100370983C Medicinal composition
02/27/2008CN100370982C Anemonin gel
02/27/2008CN100370981C Application of Maoeryisu for pharmacy
02/27/2008CN100370980C C-2' methylated derivatives of paclitaxel for use as antitumour agents
02/27/2008CN100370979C Preparation process of glucose eye lotion
02/27/2008CN100370978C Composition for treating hemorrhoids
02/27/2008CN100370977C Slow release tablet of containing active ingredient of ambroxol hydrochloride
02/27/2008CN100370976C Medicine containing shikonin compound as active component
02/27/2008CN100370975C Inhibitors against the production and releaseof inflammator cytokines
02/27/2008CN100370971C Phacolysin eye medicinal formulation
02/27/2008CN100370970C Compound red-rooted salvia preparation, and its preparing method
02/27/2008CN100370968C Quercetin long-acting liposome powder for injection and its preparing method
02/27/2008CN100370967C Implantable gel compositions and preparing method of thereof
02/27/2008CN100370965C Cleansing composition containing antifungal agent and antibacterial agent
02/27/2008CN100370928C Modern snuff and making method thereof
02/27/2008CN100370911C Method for preparing liver-benefiting, face-beautifying soybean milk tablet with micron pine pollen, pearl powder, glossy privet powder, lotus seed powder, dodder powder and wolferry fruit powder
02/27/2008CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
02/26/2008US7335961 Magnetic random access memory array with coupled soft adjacent magnetic layer
02/26/2008US7335803 Methods and compositions for modulating alpha adrenergic receptor activity
02/26/2008US7335779 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent
02/26/2008US7335777 Benzimidazole derivatives and their use for modulating the GABAA receptor complex
02/26/2008US7335776 Remedies for depression containing EP1 antagonist as the active ingredient
02/26/2008US7335774 Quinolinone derivatives
02/26/2008US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties
02/26/2008US7335772 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates
02/26/2008US7335770 Triazine compounds and their analogs, compositions, and methods
02/26/2008US7335766 dissolving an acid-soluble chitosan in organic acid; spraying the chitosan solution on salt particles to bind the chitosan to the salt particles; and drying the chitosan-bound salt particles
02/26/2008US7335765 Nucleoside and oligonucleotide analogues
02/26/2008US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer
02/26/2008US7335753 Bifunctional heterocyclic compounds and methods of making and using same
02/26/2008US7335750 Hybrid compositions for intracellular targeting
02/26/2008US7335727 fusion inhibitor; high stability and high valence; higher efficacy, and lower administration dosage, and thereby lower toxicity.
02/26/2008US7335689 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy
02/26/2008US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide
02/26/2008US7335686 Method and composition for treating osteoporosis
02/26/2008US7335684 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
02/26/2008US7335683 Compositions and methods for cystic fibrosis therapy
02/26/2008US7335682 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
02/26/2008US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis